urokinase plasminogen activator inhibitors (University of Antwerp)

N/A

Report date: 2025/01/26 17:53:18
NME

Base Information

Drug Nameurokinase plasminogen activator inhibitors (University of Antwerp)
Drug Alias NameUAMC-00050
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUrokinase plasminogen activator inhibitors
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsIrritable Bowel SyndromeNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Antwerp
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Antwerp
Inactive CompaniesN/A
Active IndicationsIrritable Bowel SyndromeNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A